Outcomes after induction failure in childhood acute lymphoblastic leukemia.

Outcomes after induction failure in childhood acute lymphoblastic leukemia.

BACKGROUND: Failure of remission-induction therapy is a rare but highly adverse event in children and adolescents with acute lymphoblastic leukemia (ALL). METHODS: We identified induction failure, defined by the persistence of leukemic blasts in blood, bone marrow, or any extramedullary site after 4...

Full description

Bibliographic Details
Main Authors:	Schrappe, M, Hunger, S, Pui, C, Saha, V, Gaynon, P, Baruchel, A, Conter, V, Otten, J, Ohara, A, Versluys, AB, Escherich, G, Heyman, M, Silverman, L, Horibe, K, Mann, G, Camitta, B, Harbott, J, Riehm, H, Richards, S, Devidas, M, Zimmermann, M
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.
by: Heerema, N, et al.
Published: (2004)

Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia - an individual patient data meta-analysis involving 5659 children
by: Yetgin, S, et al.
Published: (2010)

Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia.
by: Escherich, G, et al.
Published: (2011)

Meta-analysis of randomised trials comparing thiopurines in childhood acute lymphoblastic leukaemia
by: Escherich, G, et al.
Published: (2011)

Childhood acute lymphoblastic leukemia
by: G. Mesera, et al.
Published: (2019-09-01)

Acute lymphoblastic leukemia
by: Martin Schrappe
Published: (2018-06-01)

CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials.
by: Clarke, M, et al.
Published: (2003)

Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: Overview of 42 trials involving 12,000 randomised children
by: Richards, S, et al.
Published: (1996)

CAR T-cells for T-cell acute lymphoblastic leukemia
by: Marie Emilie Dourthe, et al.
Published: (2024-06-01)

New concepts in acute lymphoblastic leukemia frontline trials
by: Trausti Oskarsson, et al.
Published: (2018-06-01)

Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia.
by: Richards, S, et al.
Published: (2013)

The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia
by: Anna Østergaard, et al.
Published: (2023-05-01)

Hypersensitivity Reactions to Native E. coli L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction
by: Anja Möricke, et al.
Published: (2023-06-01)

Chromatin accessibility landscape of pediatric T‐lymphoblastic leukemia and human T‐cell precursors
by: Büşra Erarslan‐Uysal, et al.
Published: (2020-09-01)

Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol
by: Carmelo Rizzari, et al.
Published: (2023-06-01)

PROGNOSTIC IMPORTANCE OF MYELOSUPPRESSION DURING MAINTENANCE TREATMENT OF LYMPHOBLASTIC-LEUKEMIA
by: Dolan, G, et al.
Published: (1989)

Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.
by: Sherborne, A, et al.
Published: (2010)

Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia
by: Hiroto Inaba, et al.
Published: (2021-04-01)

Acute lymphoblastic leukemia in children
by: M. A. Maschan, et al.
Published: (2022-11-01)

P305: COMPREHENSIVE TRANSCRIPTIONAL AND CYTOGENETIC PROFILING IMPROVES CLASSIFICATION AND DETECTION OF RISK-STRATIFYING MARKERS IN THE B-OTHER PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
by: Ž. Antić, et al.
Published: (2022-06-01)

Scylla and Charybdis: Unpalatable choices in managing hypodiploid acute lymphoblastic leukemia
by: John N. Colgan, et al.
Published: (2023-12-01)

Late relapsing childhood lymphoblastic leukaemia.
by: Frost, L, et al.
Published: (1997)

Long survival in childhood lymphoblastic leukaemia.
by: Chessells, J, et al.
Published: (1987)

Immunophenotypic investigation of infant acute lymphoblastic leukemia
by: A. M. Popov, et al.
Published: (2014-07-01)

Immunophenotypic investigation of infant acute lymphoblastic leukemia
by: A. M. Popov, et al.
Published: (2014-07-01)

Late relapsing childhood lymphoblastic leukemia.
by: Vora, A, et al.
Published: (1998)

BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia
by: Buitenkamp, T, et al.
Published: (2013)

BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia.
by: Buitenkamp, T, et al.
Published: (2013)

S107: IDENTIFICATION AND CHARACTERIZATION OF GERMLINE NBN VARIANTS RELATED TO B-ALL PREDISPOSITION
by: Carolin Escherich, et al.
Published: (2023-08-01)

Late relapsing childhood acute lymphoblastic leukaemia.
by: Frost, L, et al.
Published: (1998)

Development of Thrombosis in Acute Lymphoblast Leukemia in Children
by: L.Ya. Dubey, et al.
Published: (2014-05-01)

Targeted treatment options for paediatric B-cell precursor acute lymphoblastic leukaemia patients with constitutional or somatic chromosome 21 alterations
by: Naomi Michels, et al.
Published: (2024-06-01)

Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved Diagnostics
by: Philippe Chouvarine, et al.
Published: (2021-11-01)

P360: EFFICACY AND SAFETY OF DARATUMUMAB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR LYMPHOBLASTIC LYMPHOMA: RESULTS FROM PHASE 2 DELPHINUS STUDY
by: A. Vora, et al.
Published: (2022-06-01)

PB1763: A PHASE 1/2 STUDY TO EVALUATE PONATINIB WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RELAPSED/RESISTANT/INTOLERANT PHILADELPHIA CHROMOSOME–POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OR WITH T315I MUTATION
by: L. Gore, et al.
Published: (2022-06-01)

Effect of dexamethasone on quality of life in children with acute lymphoblastic leukaemia: a prospective observational study
by: Kaspers Gert Jan L, et al.
Published: (2008-11-01)

Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia
by: Chiara Palmi, et al.
Published: (2023-06-01)

FUNCTIONAL ACTIVITY OF NEUTROPHILS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: T. G. Kadricheva, et al.
Published: (2014-07-01)

Prognostic determinants after intensified therapy of childhood lymphoblastic leukemia.
by: Vora, A, et al.
Published: (2000)

Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome
by: Elen Oliveira, et al.
Published: (2022-06-01)